Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
30333 | 139 | 30.8 | 75% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | 9 CIS UAB30 | Author keyword | 3 | 100% | 2% | 3 |
2 | NSC23925 | Author keyword | 3 | 100% | 2% | 3 |
3 | TARGRETIN | Author keyword | 3 | 60% | 2% | 3 |
4 | BEXAROTENE | Author keyword | 3 | 16% | 11% | 15 |
5 | LGD1069 | Author keyword | 1 | 50% | 1% | 2 |
6 | PATHOL ASSOC | Address | 1 | 50% | 1% | 1 |
7 | CHEMOPREVENT AGENT DEV PROGRAM | Address | 0 | 33% | 1% | 1 |
8 | CONFORMATIONALLY LOCKED | Author keyword | 0 | 33% | 1% | 1 |
9 | P53 MOUSE | Author keyword | 0 | 33% | 1% | 1 |
10 | PENTAMETHYLCHROMANOL | Author keyword | 0 | 25% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | 9 CIS UAB30 | 3 | 100% | 2% | 3 | Search 9+CIS+UAB30 | Search 9+CIS+UAB30 |
2 | NSC23925 | 3 | 100% | 2% | 3 | Search NSC23925 | Search NSC23925 |
3 | TARGRETIN | 3 | 60% | 2% | 3 | Search TARGRETIN | Search TARGRETIN |
4 | BEXAROTENE | 3 | 16% | 11% | 15 | Search BEXAROTENE | Search BEXAROTENE |
5 | LGD1069 | 1 | 50% | 1% | 2 | Search LGD1069 | Search LGD1069 |
6 | CONFORMATIONALLY LOCKED | 0 | 33% | 1% | 1 | Search CONFORMATIONALLY+LOCKED | Search CONFORMATIONALLY+LOCKED |
7 | P53 MOUSE | 0 | 33% | 1% | 1 | Search P53+++MOUSE | Search P53+++MOUSE |
8 | PENTAMETHYLCHROMANOL | 0 | 25% | 1% | 1 | Search PENTAMETHYLCHROMANOL | Search PENTAMETHYLCHROMANOL |
9 | SR13668 | 0 | 25% | 1% | 1 | Search SR13668 | Search SR13668 |
10 | OSTEOSARCORNA | 0 | 20% | 1% | 1 | Search OSTEOSARCORNA | Search OSTEOSARCORNA |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LGD1069 | 12 | 48% | 14% | 19 |
2 | 9CUAB30 | 11 | 100% | 4% | 6 |
3 | TARGRETIN PREVENTS | 11 | 78% | 5% | 7 |
4 | BEXAROTENE LGD1069 | 6 | 80% | 3% | 4 |
5 | LIGAND LGD1069 | 6 | 100% | 3% | 4 |
6 | RETINOIC ACID ANALOGS | 4 | 67% | 3% | 4 |
7 | AGONIST BEXAROTENE LGD1069 | 4 | 75% | 2% | 3 |
8 | MAMMARY CANCERS | 4 | 46% | 4% | 6 |
9 | NUCLEAR RECEPTOR BINDING | 3 | 60% | 2% | 3 |
10 | LGD1069 TARGRETIN | 2 | 27% | 6% | 8 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Lung cancer chemoprevention: difficulties, promise and potential agents? | 2013 | 9 | 69 | 22% |
Further Thoughts on Preclinical Animal Models for Cancer Prevention: When Is It Best to Start Treatment? What Are Potential Histopathologic Endpoints? | 2010 | 2 | 23 | 9% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PATHOL ASSOC | 1 | 50% | 0.7% | 1 |
2 | CHEMOPREVENT AGENT DEV PROGRAM | 0 | 33% | 0.7% | 1 |
3 | OUHSC | 0 | 17% | 0.7% | 1 |
4 | CHEMOPREVENT CANC DRUG DEV | 0 | 11% | 0.7% | 1 |
5 | ANETHESIOL UNIT | 0 | 100% | 0.7% | 1 |
6 | HEM ONC SECTPC STEPHENSON OKLAHOMA CANC | 0 | 100% | 0.7% | 1 |
7 | HITCHCOCK CANC | 0 | 100% | 0.7% | 1 |
8 | NORRIS COTTON CANC HEMATOL ONCOL SECT | 0 | 100% | 0.7% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000289153 | RETINOYLATION//RETINOBENZOIC ACID//RXR |
2 | 0.0000239380 | FENRETINIDE//4 HPR//N 4 HYDROXYPHENYL RETINAMIDE |
3 | 0.0000122400 | DEC1//DEC2//STRA13 |
4 | 0.0000121239 | ACID INDUCED INDOLE CYCLIZATION//22810 TAMAGAWA SETAGAYA KU//DECARBOXYLATIVE CYCLIZATION |
5 | 0.0000107734 | 1 METHYL 1 NITROSOUREA//MAMMARY DYSPLASIA//BREAST DIFFERENTIATION |
6 | 0.0000102101 | ENVIRONMENTAL CIGARETTE SMOKE//STRAIN A J MICE//LUNG TUMORS |
7 | 0.0000081902 | PPAR GAMMA//PPAR RESEARCH//TROGLITAZONE |
8 | 0.0000074707 | RALOXIFENE//TISSUE SELECTIVE ESTROGEN COMPLEX//BAZEDOXIFENE |
9 | 0.0000062068 | BATHORHODOPSIN//PROTONATED SCHIFF BASE//RETINAL |
10 | 0.0000049412 | RGTA//DERIVATIZED DEXTRANS//HEPARAN MIMETIC |